About
MD: Nagoya University, Nagoya, Japan, 2003.
PhD: Tokyo University, Tokyo, Japan, 2008.
Residency: Pediatrics, Columbia University, New York, NY.
Certification: Pediatrics, 2010.
Fellowship: Pediatric Gastroenterology, Hepatology and Nutrition, Northwestern University, Chicago, IL.
Certification: Pediatric Gastroenterology, Hepatology and Nutrition, 2013.
Fellowship: Advanced/Transplant Hepatology, University of Cincinnati, Cincinnati, OH.
Certification: Advanced/Transplant Hepatology.
Interests
Pediatric hepatology; pediatric transplant hepatology
Interests
Pediatric hepatology; genetic and molecular mechanism of liver development and pathophysiology
Additional Languages
Japanese
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
The Outcome of Patients With Cystic Biliary Atresia With Intact Proximal Hepatic Ducts Following Hepatic-Cyst-Jejunostomy. Journal of Pediatric Gastroenterology and Nutrition. 2022; 75:131-137.
Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency. JHEP Reports. 2022; 4:100446.
Biliary Atresia and Other Disorders of the Extrahepatic Bile Ducts. Liver Disease in Children. : Cambridge University Press (CUP); Cambridge University Press (CUP); 2021.
Modeling Human Bile Acid Transport and Synthesis in Stem Cell-Derived Hepatocytes with a Patient-Specific Mutation. Stem Cell Reports. 2021; 16:309-323.
Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nature Reviews: Gastroenterology and Hepatology. 2015; 12:342-352.
Deriving Human Intestinal Organoids with Functional Tissue-Resident Macrophages All From Pluripotent Stem Cells. CMGH Cellular and Molecular Gastroenterology and Hepatology. 2025; 19:101444.
Portal vein hypoplasia is present in patients with biliary atresia at the time of diagnosis. Journal of Pediatric Gastroenterology and Nutrition. 2024; 79:818-825.
Induced pluripotent stem cell (iPSC) modeling validates reduced GBE1 enzyme activity due to a novel variant, p.Ile694Asn, found in a patient with suspected glycogen storage disease IV. Molecular Genetics and Metabolism Reports. 2024; 39:101069.
Rapid in vivo evaluation system for cholestasis-related genes in mice with humanized bile acid profiles. Hepatology Communications. 2024; 8:e0382.
Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance. Hepatology Communications. 2023; 7:e0345.
From the Blog
Cincinnati Children’s Launches Research Center for Rare Liver Diseases
Akihiro Asai, MD, PhD, William F. Balistreri, MD ...12/6/2021
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey